Results 151 to 160 of about 15,086,688 (305)

Overcoming platinum resistance by the disulfiram metabolite CuET in novel preclinical models of human carcinomas

open access: yesMolecular Oncology, EarlyView.
Cisplatin‐resistant cancer cells survive DNA‐damaging platinum‐based treatment yet remain sensitive to CuET‐induced proteotoxic stress. The distinct mechanism of action allows CuET to overcome and eliminate cisplatin‐resistant tumour cells, unless highly expressed metallothioneins (MTs) interfere with CuET, thereby highlighting MT levels as candidate ...
Stefanos Arampatzis   +20 more
wiley   +1 more source

Decision-Making Capacity Assessment Education using Online Modules. [PDF]

open access: yesCan Geriatr J
Charles L   +5 more
europepmc   +1 more source

An outer membrane vesicle‐associated two‐track model for enterotoxigenic Bacteroides fragilis oncogenesis

open access: yesMolecular Oncology, EarlyView.
Enterotoxigenic Bacteroides fragilis is a gut bacterium linked to bowel cancer. We propose that its toxin acts along two routes: at the cell surface, cutting the adhesion protein E‐cadherin and triggering inflammation; and inside the cell, delivered by bacterial vesicles, switching on NOD1 and cancer stem cell programs.
Kangchan Choi   +2 more
wiley   +1 more source

Does cognitive performance decline as a function of age at onset in Parkinson's disease? the role of age at assessment, education, and clinical severity. [PDF]

open access: yesAging Clin Exp Res
Morales-de-Arcia AA   +23 more
europepmc   +1 more source

Fall hiring report. School Year. 2004.

open access: yes, 1987
Annual; Sept. 1, 1987-; Earlier issue, 1987, cataloged as a monograph in LC.; Title from cover.; "In accordance with Section 10a-163 of the Connecticut General Statutes"--P. v (Sept.

core  

Immune potentiating effects of the HDAC inhibitor Zabadinostat on human immune and tumor cells

open access: yesMolecular Oncology, EarlyView.
Zabadinostat (CXD101) is a second‐generation class I histone deacetylase inhibitor (HDACi). We show that Zabadinostat activates human T cells and natural killer cells while reducing frequencies and function of regulatory T cells. Zabadinostat also increases T cell stemness and modulates tumor cell phenotype to potentially enhance immune recognition ...
Stephanie C. Pitts   +15 more
wiley   +1 more source

Osimertinib resistance in non‐small cell lung cancer is mediated by sustained AKT activation through lipid raft‐dependent insulin signaling

open access: yesMolecular Oncology, EarlyView.
Osimertinib is effective against EGFR‐mutant NSCLC, but resistance often develops. We found that increased cholesterol in lipid rafts, specialized regions of the cell membrane, promotes recruitment of the scaffold protein FLOT1 and insulin receptors.
Yen‐Lin Lai   +2 more
wiley   +1 more source

Fall hiring report. School Year: 1998-1999.

open access: yes, 1987
Annual; Sept. 1, 1987-; Earlier issue, 1987, cataloged as a monograph in LC.; Title from cover.; "In accordance with Section 10a-163 of the Connecticut General Statutes"--P. v (Sept.

core  

Home - About - Disclaimer - Privacy